Together we will beat cancer


First treatment approved in England for advanced bile duct cancer

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

Read More

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.

Read More

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

Read More